Efficacy and safety of long-acting pasireotide or...

The Lancet Oncology 2017 / 10

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

Ferolla, Piero, Brizzi, Maria Pia, Meyer, Tim, Mansoor, Wasat, Mazieres, Julien, Do Cao, Christine, Léna, Hervé, Berruti, Alfredo, Damiano, Vincenzo, Buikhuisen, Wieneke, Grønbæk, Henning, Lombard-Boh
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30681-2
Date:
October, 2017
File:
PDF, 387 KB
english, 2017
Conversion to is in progress
Conversion to is failed